Yahoo
    Shenzhen - Delayed Quote CNY

    Aier Eye Hospital Group Co., Ltd. (300015.SZ)

    8.93 +0.25 (+2.88%)
    At close: 3:04:58 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 300015.SZ
    • Previous Close 8.68
    • Open 8.20
    • Bid 8.93 x --
    • Ask 8.94 x --
    • Day's Range 8.66 - 8.96
    • 52 Week Range 7.67 - 12.54
    • Volume 129,926,689
    • Avg. Volume 61,780,286
    • Market Cap (intraday) 82.879B
    • Beta (5Y Monthly) 0.38
    • PE Ratio (TTM) 34.35
    • EPS (TTM) 0.26
    • Earnings Date --
    • Forward Dividend & Yield 0.18 (2.07%)
    • Ex-Dividend Date Jul 17, 2026
    • 1y Target Est 12.04

    Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.

    www.aierchina.com

    42,817

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Medical Care Facilities

    Industry

    More about Aier Eye Hospital Group Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    300015.SZ
    17.19%
    SSE Composite Index (000001.SS)
    9.09%

    1-Year Return

    300015.SZ
    25.53%
    SSE Composite Index (000001.SS)
    9.26%

    3-Year Return

    300015.SZ
    49.26%
    SSE Composite Index (000001.SS)
    19.05%

    5-Year Return

    300015.SZ
    66.53%
    SSE Composite Index (000001.SS)
    3.13%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q3 FY26
    Revenue 6.4B
    Earnings 940.7M
    Profit Margin 14.70%

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    Q3

    FY26

    0
    2B
    4B
    6B
    0.0%
    5.0%
    10.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    7.50 Low
    12.04 Average
    8.93 Current
    15.79 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      10.44%

    • Return on Assets (ttm)

      8.65%

    • Return on Equity (ttm)

      11.04%

    • Revenue (ttm)

      23.21B

    • Net Income Avi to Common (ttm)

      2.42B

    • Diluted EPS (ttm)

      0.26

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      6.71B

    • Total Debt/Equity (mrq)

      31.62%

    • Levered Free Cash Flow (ttm)

      3.06B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    300760.SZ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    185.86 +3.66%
    600276.SS Jiangsu Hengrui Pharmaceuticals Co.,Ltd
    49.31 +1.27%
    300122.SZ Chongqing Zhifei Biological Products Co., Ltd.
    14.56 +4.97%
    603288.SS Foshan Haitian Flavouring and Food Company Ltd.
    36.39 +3.38%
    300059.SZ East Money Information Co.,Ltd.
    18.86 +0.80%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: